Seelos Therapeutics Inc (SEEL) Stock: What Does the Chart Say?

Tuesday, September 29, 2020 3:20 PM | InvestorsObserver Analysts

The market has been high on Seelos Therapeutics Inc (SEEL) stock recently. SEEL gets a Bullish score from InvestorsObserver's Stock Sentiment Indicator.

Sentiment Score - ,bullish
Seelos Therapeutics Inc has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on SEEL!

What is Stock Sentiment?

Sentiment is a very short-term indicator that is entirely technical. There is no information about the health of profitability of the underlying company in our sentiment score.

As a technical indicator, news about the stock, or company, such as an earnings release or other event, could move the stock counter to the recent trend.

Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down.

InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend.

Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With SEEL Stock Today?

Seelos Therapeutics Inc (SEEL) stock is trading at $0.99 as of 3:17 PM on Tuesday, Sep 29, a gain of $0.21, or 26.86% from the previous closing price of $0.78. The stock has traded between $0.83 and $1.07 so far today. Volume today is above average. So far 12,158,497 shares have traded compared to average volume of 1,449,370 shares.

To see the top 5 stocks in the Biotechnology industry click here.

More About Seelos Therapeutics Inc

Seelos Therapeutics Inc is engaged in the pharmaceutical industry. The company's pipeline products include SLS-002 which is intranasal racemic ketamine for patients with suicidality in post-traumatic stress disorder and depressive disorder; SLS-006 which is a small molecule, partial dopamine agonist for Parkinson's Disease; and SLS-005 is Trehalose, a protein stabilizer. Its other pipeline products include SLS-007, SLS-008, SLS-004, SLS-010, and SLS-012.

Click Here to get the full Stock Score Report on Seelos Therapeutics Inc (SEEL) Stock.

Share this article:

Related Companies

Upgrade to Premium and Analyze Stocks Like a Pro

50% Off All Subscriptions
InvestorsObserver Premium
InvestorsObserver Premium
InvestorsObserver Premium
Save up to 65% with annual

InvestorsObserver Premium

$ 20.75 $ 10.38 /month
$249 $124.50 billed annually

You May Also Like